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Abstract
Background: Although magnesium ions (Mg2+) are known to display many similar features to
other 2+ charged cations, they seem to have quite an important and unique role in biological
settings, such as NMDA blocking effect. However, the role of Mg2+ in the neural transmission
system has not been studied as sufficiently as calcium ions (Ca2+). To clarify the sensory effects of
Mg2+ in peripheral nervous systems, sensory changes after intradermal injection of Mg2+ were
studied in humans.
Methods: Magnesium sulphate, magnesium chloride and saline were injected into the skin of the
anterior region of forearms in healthy volunteers and injection-induced irritating pain ("irritating
pain", for short), tactile sensation, tactile pressure thresholds, pinch-pain changes and intolerable
heat pain thresholds of the lesion were monitored.
Results: Flare formation was observed immediately after magnesium sulphate or magnesium
chloride injection. We found that intradermal injections of magnesium sulphate and magnesium
chloride transiently caused irritating pain, hypesthesia to noxious and innocuous mechanical
stimulations, whereas secondary hyperalgesia due to mechanical stimuli was not observed. In
contrast to mechanical stimuli, intolerable heat pain-evoking temperature was significantly
decreased at the injection site. In addition to these results, spontaneous pain was immediately
attenuated by local cooling.
Conclusion: Membrane-stabilizing effect and peripheral NMDA-blocking effect possibly produced
magnesium-induced mechanical hypesthesia, and extracellular cation-induced sensitization of
TRPV1 channels was thought to be the primary mechanism of magnesium-induced heat
hyperalgesia.
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Background
Although magnesium ions (Mg2+) are widely distributed
throughout the whole organ, the role of Mg2+ in the neural
transmission system has not been studied as sufficiently
as calcium ions (Ca2+). Much research has mentioned that
Mg2+ shows a similar physiological attitude to Ca2+ and it
has been reported that both ions have a membrane-stabi-
lizing effect on nerves [1,2]. In addition, Mg2+ is known to
act as a competitor to Ca2+, in extracellular matrix [3].
However, the specific role of Mg2+ in neurophysiological
transmission, especially concerning peripheral somato-
sensory systems, has been insufficiently focused on and
not understood enough.
Among the various studies, the noncompetitive antago-
nistic action of Mg2+ on N-methyl-D-aspartate (NMDA)
receptor, a glutamate receptor, was the focus of various
reports [4]. Although the role of spinally-located NMDA
receptors has been the focus of pain-related research
before, NMDA receptors are also known to exist in periph-
eral nervous system [5]. Carlton et al. reported an
increased population of peripheral glutamate receptors in
injured peripheral nerve tissue [6]. In a previous study,
Iwatsu et al. reported that intradermal administration of
NMDA receptor antagonists, ketamin hydrochloride and
magnesium sulphate, produces hypesthesia to mechani-
cal stimuli in humans [7]. Therefore, Mg2+ may alter neu-
ronal activities both centrally and peripherally.
Concerning therapeutic effects, magnesium sulphate is
known to improve types of pain in humans and animals
[8]. On the other hand, Mikkelsen et al. reported that
intravenous injection of Mg2+ (magnesium sulphate) pro-
duces heat hyperalgesia in humans [9].
Since much previous research has reported contradictory
results, it is necessary to organize human investigation to
clarify real changes of sensory experiences after adminis-
trations of Mg2+. In our healthy volunteer study, subjects
were asked to estimate the degree of pain and the effect of
the drug was examined. In addition to noxious mechani-
cal stimulation and noxious radiant heat stimulation, we
performed an experiment evaluating innocuous mechan-
ical stimulation, such as tactile sensation, in order to
investigate the effect of intradermally applied magnesium
sulphate (MS) and magnesium chloride (MC).
Methods
Fifteen healthy volunteers (age ranged from 26 to 34
years, mean: 29 years) were enrolled in sensory testing
study after intradermal injection of magnesium ions and
another 15 healthy volunteers (age ranged from 22 to 43
years, mean: 28 years) were enrolled in the experiment for
examining the effect of local cooling in Mg2+ ion induced
irritating pain study. All protocols were conducted in
accordance with the recommendations outlined in the
Declarations of Helsinki and were approved by the local
Medical Ethical Committee. All subjects agreed to the
study protocols and signed an informed consent form
prior to the examination.
Sensory testing study after intradermal injection of 
magnesium ion
Using the double-blind method, each subject (n = 15)
received one intradermal injection of 0.5 M MS (0.1 ml,
524 mOSM) into one anterior ulnar site on the forearm
and one injection of physiological saline (0.1 ml, 0.9%
NaCl, 290 mOSM) at the same site into the other forearm
as a control. At least one week after injection of 0.5 M MS,
the same subjects received one injection of 0.05 M MS
(0.1 ml, 337 mOSM) and saline in the same way. With
0.05 M MC and physiological saline solutions, they were
injected with MC (0.1 ml, 385 mOSM) and physiological
saline (0.1 ml) under the same procedure at least one
week later. Therefore, each subject received one injection
of 0.5 M & 0.05 M MS, and 0.05 M MC, and three injec-
tions of saline. Following injection, the resulting effects
were evaluated after 1, 10, 20, 30, 45 and 60 min. for the
MS site, MC site and NaCl site. The following tests were
undertaken in a quiet room and room temperature was
maintained at 25°C. Skin surface around the injection
(test) area was kept at 34°C by servo-controlled thermal
controller (Dantec Dynamics, Skovlunde, Denmark).
Injection-induced irritating pain evaluation
The intensity of irritating pain was evaluated by 100 mm
visual analogue scale ('VAS') before and after injection of
test solutions.
Tactile sensation evaluation
Using a horse hair brush, tactile sensations at the wheal
region formed by intradermal injection and the region of
unaffected skin were compared. Rating the sense of nor-
mal skin on the same arm as 10, the tactile sensation at the
wheal region was evaluated using a numeric rating scale
('NRS').
Tactile pressure threshold test
Using the von Frey filaments, the tactile pressure thresh-
old in intradermally injected area was measured. Prior to
this experiment, pressure force of each von Frey filament
was calibrated.
Pinch-pain evaluation test
Using an arterial clamp, the pain intensity evoked by
pinch at the wheal region formed by intradermal injection
and unaffected normal proximal skin were compared.
Rating the sense of pain of normal skin on the same arm
as 10, the pain intensity at the wheal region was evaluated
using NRS. In addition, same pinch (noxious mechanical)Journal of Neuroinflammation 2009, 6:25 http://www.jneuroinflammation.com/content/6/1/25
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stimulations were applied to the skin, located 1 cm apart
from wheal region to check existence of secondary hyper-
algesia.
Measurement of intractable heat pain evoking 
temperature 
Thermal stimulation was applied by Peltier probe control-
ler (Intercross-200, Intercross Co., Tokyo, Japan). Tip of
the probe (2.5 × 2.5 cm) was applied to injection site and
temperature of the probe was serially increased from 30 to
50°C (+0.5°C/sec.). Experimental subjects were
instructed to push a button when they experienced intol-
erant heat pain sensation (The threshold temperature that
induces intolerable heat pain). After pushing the button,
the temperature of the probe was programmed to auto-
matically return quickly to 30°C.
Changes in injection-induced irritating pain after cooling
After intradermal administration of MS (0.5 M), graded
cooling stimuli (from 25 to 9°C: -0.5 – -2.1°C/sec) were
applied to the injection site by Peltier probe controller
(UDH-300, Unique Medical Co., Tokyo, Japan) (Fig. 1)
and the intensity of irritating pain at each test temperature
was recorded by NRS.
Statistical Analysis
All data are expressed as mean ± S.E.M Significant changes
over time were determined with the Friedman's analysis
of variance by ranks followed by post hoc pairwise com-
parisons.
Results
Local observation and injection-induced irritating pain 
evaluation
All test solutions containing Mg2+ produced flare forma-
tion around the injection site and irritating pain. The
intensity of irritating pain evaluated by VAS showed a sig-
nificant increase at 1–10 min after the injection of 0.5 M
and 0.05 M MS. Furthermore, MC produced irritating
pain at 1 min after injection. (Fig. 2A)
Tactile sensation evaluation
After injection of MS, tactile sensation caused by brush
decreased up to 20 min and by 1–10 min after injection of
0.5 M and 0.05 M MS respectively, and by 1–10 min after
injection of 0.05 M MC (Fig. 2B) compared with the con-
trol level.
Tactile pressure threshold test
The tactile pressure threshold measured using the von
Frey filaments significantly increased up to 20 min and by
1–10 min after injection of 0.5 M and 0.05 M MS respec-
tively, and up to 20 min after injection of MC compared
with saline. (Fig. 2C)
Pinch-pain evaluation test
The pinch-pain evoked by an arterial clamp was reduced
up to 10 min after injection of 0.5 M and 0.05 M MS. Sim-
ilar but shorter changes were observed after injection of
MC. (Fig. 2D)
In addition apparent secondary hyperalgesia was not
detected in flare area.
Measurement of intolerable heat pain evoking 
temperature
The threshold temperature that induces intolerable heat
pain was decreased up to 20 min and by 1–10 min after
intradermal injection of 0.5 M and 0.05 M MS respec-
tively. Similarly MC decreased the pain evoking tempera-
ture up to 20 min after injection.
In contrast, intradermal injection of saline did not alter
the intolerable heat pain threshold. (Fig. 3)
Effect of local cooling in Mg2+ ion-induced irritating pain
Cooling of the surface of the injected area apparently
attenuated irritating pain. (Fig. 4) Furthermore, local flare
did not change after local cooling.
Discussion
In the present study, both MS and MC solutions but not
saline, inhibited the sensations evoked by noxious and
innocuous mechanical stimuli but produced irritating
pain. Several possible mechanisms can explain the Mg2+
ion-induced mechanical hypesthesia. As a general effect of
the excitable membrane, changes in external divalent cat-
ions are considered to alter membrane surface potential
and therefore, a high concentration of Mg2+ may inhibit
the excitability of the axon by raising the electrical thresh-
old of the membrane directly [2,10]. In pain-related poly-
Schematic diagram of the graded cooling stimuli Figure 1
Schematic diagram of the graded cooling stimuli. To 
check changes in spontaneous pain appearing at the injection 
site, Peltier probe was directly attached to the injection site 
and cooled the skin in gradual increments.Journal of Neuroinflammation 2009, 6:25 http://www.jneuroinflammation.com/content/6/1/25
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modal receptors, Sato et al. showed that reduction of
extracellular Ca2+  augmented the neuronal responses
caused by hypertonic saline and high K solutions and also
showed the augmented neuronal responses returned to
control levels by an addition of Mg2+, which suggests Mg2+
has a similar membrane-stabilizing effect on nerves to
Ca2+[11].
In addition, Chaban indicated that NMDA receptors on
the periphery are involved in the transmission of noxious
mechanical stimulation [12]. Only little attention has
being paid so far to the functional importance of the
peripherally-distributed NMDA receptors [7]. In a previ-
ous study, Ushida et al. evaluated the importance of
mechanical stimulation by studying the relationship
between magnesium ions and peripheral NMDA recep-
tors [13]. It was found that injection of MK-801, an
NMDA receptor antagonist, into the peripheral skin of rats
produces inhibition of the sensations induced by innocu-
ous and noxious stimulation.
Paradoxically, present results have shown that local
administration of Mg2+ induces heat hyperalgesia, but
mechanical hypesthesia at the injection site. Only a few
Time course of changes in effect of magnesium ion on pain and sensations Figure 2
Time course of changes in effect of magnesium ion on pain and sensations. Fifteen volunteers were intradermally 
injected with 0.5 M MgSO4 (black square), 0.05 M MgSO4 (white square), 0.05 M MgCl2 (black triangle), or saline (white circle). 
Each volunteer was injected with three kinds of magnesium solution at intervals of at least one week. Local spontaneous pain 
(A) was reported by visual analogue scale (VAS), Tactile sensation (B) and pinch pain intensity (D) were reported by a numeri-
cal rating score (NRS). When MgSO4 and MgCl2 solutions were injected, transient irritating pain and local hypesthesia to 
mechanical stimuli appeared at the injection site. *p < 0.05 vs. control; **p < 0.01 vs. control, ***p < 0.001 vs. control. As val-
ues were similar among these three saline injections, we have put the representative data herein.Journal of Neuroinflammation 2009, 6:25 http://www.jneuroinflammation.com/content/6/1/25
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researchers have paid attention to changes in Mg2+  -
induced thermal sensations. Oral administration [14] and
intrathecal injection [15] of magnesium sulphate are
reported to improve heat hyperalgesia in animal models
of neuropathic pain. On the other hand, Mikkelsen et al.
reported that intravenous infusion of magnesium had no
analgesic effect on thermal sensation in hyperalgesic skin
but produced a decreased heat detection threshold and
increased pain caused by 1 min long 45°C heat stimula-
tion [9]. Since we could not find any sensory changes out-
side of wheals, peripheral mechanisms were suggested to
explain magnesium-induced heat hyperalgesia.
Recently, transient receptor potential cation channel, sub-
family V, member 1 (TRPV1), a heat-sensitive ion chan-
nel, has been discovered [16] and the role of this channel
may be implicated in Mg2+-induced heat hyperalgesia
observed in our study. Indeed, Ahern et al. showed extra-
cellular cations such as Na+, Ca2+, Mg2+ modulate/open
the gates of TRPV1 channel by in vitro whole cell and sin-
gle channel patch-clamp recording studies [17]. In addi-
tion to this direct mechanism, several neuropeptides and
inflammatory mediators may be implicated in the
enhanced activation of TRPV1. The flare formation
observed at the injection site suggesting existence of
axonal reflex-induced neuropeptide (SP, CGRP, etc)
release from sensory nerve endings and released SP may
result in sensitizing TRPV1 via activation of NK1, a SP
receptor [18]. Also these inflammatory processes may acti-
vate the production of bradykinin (BK), a novel algesic
substance. Increased extracellular concentration of BK
results in sensitization and activates TRPV1 currents via
PLC, PKC, and lipoxygenase-derived products [19-21].
These previous studies suggest that TRPV1 may be impli-
cated in Mg2+ -induced hyperalgesia. Since cooling is
known to desensitize local TRPV1, attenuation of Mg2+ -
induced irritating pain by local cooling observed in our
present study may also be explained by this mechanism.
Recently, types of thermal-sensing receptors such as
TRPM8 (Transient receptor potential cation channel, sub-
family M, member 8: cool receptor), TRPA1 (transient
receptor potential cation channel, member A1: cold recep-
tor), etc. have been discovered after TRPV1 and have been
widely investigated [22,23]. In clinical settings, various
types of diseases and patients possess the symptoms of
thermal (heat, cold) hyperalgesia. However, it has been
problematic under such settings to specify the underlying
pathological mechanisms in these patients. Presumably,
expression or activation of these recently discovered ther-
mal receptors may play a key role in thermal pain and fur-
ther translational research is necessary for the
understanding and treatment of these intractable pain
syndromes.
Changes in experienced pain intensity by local cooling Figure 4
Changes in experienced pain intensity by local cool-
ing. After intradermal administration of 0.5 M MgSO4, Peltier 
probe was directly attached to the injection site. Pain inten-
sity was substantially attenuated according to the cooling 
temperature. (n = 15)
Time course of changes in intolerable heat pain evoking tem- perature after intradermal injection of magnesium solution Figure 3
Time course of changes in intolerable heat pain evok-
ing temperature after intradermal injection of mag-
nesium solution. Fifteen volunteers were intradermally 
injected with 0.5 M MgSO4 (black square), 0.05 M MgSO4 
(white square), 0.05 M MgCl2 (black triangle), or saline (white 
circle). Each volunteer was injected with three kinds of mag-
nesium solution at intervals of at least one week. Intolerant 
heat pain temperature was decreased at least 10 min follow-
ing local administration of Mg2+. *p < 0.05 vs. control; **p < 
0.01 vs. control, ***p < 0.001 vs. control. As values were 
similar among these three saline injections, we have put the 
representative data herein.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Neuroinflammation 2009, 6:25 http://www.jneuroinflammation.com/content/6/1/25
Page 6 of 6
(page number not for citation purposes)
Conclusion
Intradermal administration of magnesium ions locally
affected sensory systems and produced spontaneous pain,
hypesthesia to both noxious and innocuous mechanical
stimuli, and decreased the heat pain threshold. Activation
of TRPV1 channel is the suggested mechanism for the
development of heat hyperalgesia.
Abbreviations
MS: magnesium sulphate; MC: magnesium chloride;
NMDA: N-methyl-D-aspartate; TRPV1: transient receptor
potential cation channel, subfamily V, member 1; SP: sub-
stance P; CGRP: calcitonin gene-related peptide; NK-1:
neurokinin 1; BK: bradykinin; PLC: phospholipase C;
PKC: protein kinase C; TRPM8: transient receptor poten-
tial cation channel, subfamily M, member 8; TRPA1: tran-
sient receptor potential cation channel, member A1
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
TU conceived of the study, participated in its study, and
conducted all experiments. OI, KS (Shimo) and TT con-
ducted the acquisition of data. MI and TI performed the
statistical analysis. YAP, MN and KS (Suetomi) helped to
draft the manuscript. All authors read and approved the
final manuscript.
Acknowledgements
The authors would like to express their gratitude to Professor T. Tani and 
Dr. J. Sato for their invaluable comments on the manuscript and to Ms. Taki 
for technical assistance.
References
1. Fawcett WJ, Haxby EJ, Male DA: Magnesium: physiology and
pharmacology.  Br J Anaesth 1999, 83:302-320.
2. Frankenhaeuser B, Hodgkin AL: The action of calcium on the
electrical properties of squid axons.  J Physiol 1957, 137:218-244.
3. Hubbard JI, Jones SF, Landau EM: On the mechanism by which
calcium and magnesium affect the release of transmitter by
nerve impulses.  J Physiol 1968, 196:75-86.
4. Gean PW, Shinnick-Gallagher P: Epileptiform activity induced by
magnesium-free solution in slices of rat amygdala: antago-
nism by N-methyl-D-aspartate receptor antagonists.  Neurop-
harmacology 1988, 27:557-562.
5. Coggeshall RE, Carlton SM: Ultrastructural analysis of NMDA,
AMPA, and kainate receptors on unmyelinated and myeli-
nated axons in the periphery.  J Comp Neurol 1998, 391:78-86.
6. Carlton SM, Coggeshall RE: Inflammation-induced changes in
peripheral glutamate receptor populations.  Brain Res 1999,
820:63-70.
7. Iwatsu O, Ushida T, Tani T, Nada Bashir L, Yamamoto H: Peripheral
Administration of Magnesium Sulfate and Ketamine Hydro-
chloride Produces Hypesthesia to Mechanical Stimuli in
Humans.  Journal of health science 2002, 48:69-72.
8. Dube L, Granry JC: The therapeutic use of magnesium in
anesthesiology, intensive care and emergency medicine: a
review.  Can J Anaesth 2003, 50:732-746.
9. Mikkelsen S, Dirks J, Fabricius P, Petersen KL, Rowbotham MC, Dahl
JB: Effect of intravenous magnesium on pain and secondary
hyperalgesia associated with the heat/capsaicin sensitization
model in healthy volunteers.  Br J Anaesth 2001, 86:871-873.
10. Hahin R, Campbell DT: Simple shifts in the voltage dependence
of sodium channel gating caused by divalent cations.  J Gen
Physiol 1983, 82:785-805.
11. Sato J, Mizumura K, Kumazawa T: Effects of ionic calcium on the
responses of canine testicular polymodal receptors to algesic
substances.  J Neurophysiol 1989, 62:119-125.
12. Chaban VV, Li H, Ennes HS, Nie J, Mayer EA, McRoberts JA: N-
methyl-D-aspartate receptors enhance mechanical
responses and voltage-dependent Ca2+ channels in rat dorsal
root ganglia neurons through protein kinase C.  Neuroscience
2004, 128:347-357.
13. Ushida T, Tani T, Kawasaki M, Iwatsu O, Yamamoto H: Peripheral
administration of an N-methyl-D-aspartate receptor antag-
onist (MK-801) changes dorsal horn neuronal responses in
rats.  Neurosci Lett 1999, 260:89-92.
14. Hasanein P, Parviz M, Keshavarz M, Javanmardi K, Mansoori M, Soltani
N: Oral magnesium administration prevents thermal hyper-
algesia induced by diabetes in rats.  Diabetes Res Clin Pract 2006,
73:17-22.
15. Xiao WH, Bennett GJ: Magnesium suppresses neuropathic pain
responses in rats via a spinal site of action.  Brain Res 1994,
666:168-172.
16. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skin-
ner K, Raumann BE, Basbaum AI, Julius D: The cloned capsaicin
receptor integrates multiple pain-producing stimuli.  Neuron
1998, 21:531-543.
17. Ahern GP, Brooks IM, Miyares RL, Wang XB: Extracellular cations
sensitize and gate capsaicin receptor TRPV1 modulating
pain signaling.  J Neurosci 2005, 25:5109-5116.
18. Zhang H, Cang CL, Kawasaki Y, Liang LL, Zhang YQ, Ji RR, Zhao ZQ:
Neurokinin-1 receptor enhances TRPV1 activity in primary
sensory neurons via PKCepsilon: a novel pathway for heat
hyperalgesia.  J Neurosci 2007, 27:12067-12077.
19. Premkumar LS, Ahern GP: Induction of vanilloid receptor chan-
nel activity by protein kinase C.  Nature 2000, 408:985-990.
20. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI,
Chao MV, Julius D: Bradykinin and nerve growth factor release
the capsaicin receptor from PtdIns(4,5)P2-mediated inhibi-
tion.  Nature 2001, 411:957-962.
21. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, Kim SH, Lee MG,
Choi YH, Kim J, Haber NA, Reichling DB, Khasar S, Levine JD, Uhtaek
Oh:  Bradykinin-12-lipoxygenase-VR1 signaling pathway for
inflammatory hyperalgesia.  Proc Natl Acad Sci USA 2002,
99:10150-10155.
22. Obata K, Katsura H, Mizushima T, Yamanaka H, Kobayashi K, Dai Y,
Fukuoka T, Tokunaga A, Tominaga M, Noguchi K: TRPA1 induced
in sensory neurons contributes to cold hyperalgesia after
inflammation and nerve injury.  J Clin Invest 2005,
115:2393-2401.
23. Tominaga M, Caterina MJ: Thermosensation and pain.  J Neurobiol
2004, 61:3-12.